Addex Therapeutics LtdADXNNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR-14.1%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-14.1%/yr
Quarterly compound
Percentile
P90
Near historical high
vs 3Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 34.74% |
| Q2 2025 | -42.00% |
| Q1 2025 | -23.97% |
| Q4 2024 | 22.93% |
| Q3 2024 | -112.08% |
| Q2 2024 | 510.09% |
| Q1 2024 | -5.67% |
| Q4 2023 | 11.50% |
| Q3 2023 | 8.63% |
| Q2 2023 | 5.60% |
| Q1 2023 | 35.78% |
| Q4 2022 | 28.84% |
| Q3 2022 | 54.74% |
| Q2 2022 | -26.67% |
| Q1 2022 | -15.38% |
| Q4 2021 | -18.18% |
| Q3 2021 | 21.43% |
| Q2 2021 | -77.89% |
| Q1 2021 | 0.88% |
| Q4 2020 | 33.83% |
| Q3 2020 | 0.00% |
| Q2 2020 | 25.00% |
| Q1 2020 | -14.29% |
| Q4 2019 | 0.00% |
| Q3 2019 | 17.65% |
| Q2 2019 | -41.67% |
| Q1 2019 | -59.79% |
| Q4 2018 | 0.00% |
| Q3 2018 | -225.17% |
| Q2 2018 | 18.58% |
| Q1 2018 | 188.46% |
| Q4 2017 | 0.00% |
| Q3 2017 | 20.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | -0.85% |
| Q4 2016 | 0.00% |
| Q3 2016 | -28.91% |
| Q2 2016 | 17.91% |
| Q1 2016 | -4.69% |
| Q4 2015 | 0.00% |